natgillin/translations-raw huggingface dataset:
Effective contraception must be used during treatment and for at least 6 months after Oncaspar discontinuation.
Med zdravljenjem in še najmanj 6 mesecev po prekinitvi zdravljenja z zdravilom Oncaspar je treba uporabljati učinkovito kontracepcijo.
Effective contraceptive measures must be taken by women of child-bearing potential (see section 4.6).
Ženske v rodni dobi morajo uporabljati učinkovito obliko kontracepcije (glejte poglavje 4.6)
Effective contraceptive measures must be taken by women of child-bearing potential.
Ženske v rodni dobi morajo uporabljati učinkovito kontracepcijsko zaščito.
Effective contraceptive precautions must be taken by both male and female patients who are taking Temomedac (see also “Male fertility” below).
Bolnice in bolniki, ki jemljejo zdravilo Temomedac, morajo uporabljati učinkovito kontracepcijsko metodo (glejte tudi spodaj Plodnost pri moških).
Effective contraceptive precautions must be taken by both male and female patients who are taking Temozolomide SUN (see also “Male fertility” below).
Bolnice in bolniki, ki jemljejo zdravilo Temozolomid SUN, morajo uporabljati učinkovito kontracepcijsko metodo (glejte tudi spodaj Plodnost pri moških)
Effective contraceptive precautions must be taken by both male and female patients who are using Temodal (see also “Male fertility” below).
Bolnice in bolniki, ki jemljejo zdravilo Temodal, morajo uporabljati učinkovito kontracepcijsko metodo (glejte tudi spodaj Plodnost pri moških).
Effective contraceptive precautions must be taken by patients who are taking Capecitabine SUN.
Bolniki, ki jemljejo zdravilo Kapecitabin SUN, morajo uporabljati učinkovito kontracepcijsko metodo.
Effective Dose
Učinkovit odmerek
effective dose ( Sv/1 GBq administered)
učinkovit odmerek (Sv/1 GBq)
Effective dose (E) (females, mSv/MBq)
Učinkoviti odmerek (E) (ženske, mSv/MBq)
Effective Dose (mSv/MBq)
Raven odmerka, pri katerem se pokaže učinek (mSv/MBq)
Effective dose (mSv/MBq)
učinkovit odmerek (mSv/MBq)
Effective Dose (mSv/MBq)
Učinkoviti odmerek (mSv/MBq)
Effective dose (Sv/1 GBq administered)
Efektivna doza (aplicirani Sv/1GBq)
Effective Dose 0.00863 mSv / MBq
Efektivni odmerek 0,00863 mSv/MBq
Effective Dose [µSv/MBq]a
Učinkoviti odmerek [µSv/MBq]a
Effective Dose Equivalent*
ekvivalent efektivne doze
Effective Dose*
efektivna doza
Effective half-life (h)
efektivna razpolovni čas (h)
Effective therapy in treatment experienced patients is associated with a Cmin of approximately 100 ng/ml and an AUC0-24 of about 20,000 ng·h/ml.
Učinkovito terapijo že zdravljenih bolnikov povezujejo s Cmin približno 100 ng/ml in AUC0-24 okoli 20.000 ng·h/ml.
Effectiveness after 2 doses in preventing RVGE leading to hospitalisation
Učinkovitost po 2 odmerkih za preprečevanje RVGE, ki povzroči sprejem v bolnišnico
Effectiveness study data
Rezultati študije učinkovitosti
Effectiveness was also measured in other ways including ‘haematological response’ (a return to normal of the number of white cells in the blood).
Učinkovitost so merili tudi drugače, vključno s „hematološkim odzivom‟ (vrnitvijo števila belih krvničk v krvi na običajno raven).
Effectiveness was determined based on the need to provide analgesic treatment (pain relief) to cats following surgery.
Učinkovitost so merili na podlagi potrebe po dodatnem protibolečinskem zdravljenju (lajšanju bolečin) pri mačkah po operativnem posegu.
Effectiveness was measured based on the number of relapses, and the changes in the patients’ level of disability measured using a standard scale (the Expanded Disability Status Scale).
Učinkovitost je bila merjena na osnovi števila recidivov in spremembe v stopnji bolnikove prizadetosti, merjene z uporabo standardne lestvice (razširjena lestvica stopnje prizadetosti (EDSS)).
Effectiveness was measured by identifying adult worm segments (tapeworms) or counting worm eggs (roundworms) in faeces at day 14 after treatment.
Učinkovitost so merili z ugotavljanjem segmentov odraslih črvov (trakulj) ali štetjem jajčec črvov (glist) v blatu 14. dan po zdravljenju.
Effectiveness was measured by the number of fleas at day 2 and day 30 after treatment.
Učinkovitost so merili s številom bolh 2. in 30. dan po zdravljenju.
Effectiveness was measured by the number of ticks at day 30 after treatment.
Učinkovitost so merili s številom klopov 30. dan po zdravljenju.
Effects associated with stimulation of the AT2 receptor such as vasodilatation, natriuresis and inhibition of inappropriate cell growth are not suppressed.
Koristni učinki stimulacije receptorjev AT2, kot so vazodilatacija, natriureza in zaviranje neustrezne celične rasti niso zavirani.
Effects described include central nervous system (CNS) stimulation such as convulsion, irritability, restlessness and jitteriness, cardiac effects such as tachycardia, arrhythmia, hypertension and increased stroke volume, metabolism and nutrition disorders such as hyperglycaemia.
Opisani učinki vključujejo spodbujanje osrednjega živčnega sistema (OŽS) kot so konvulzije, razdražljivost, nemir in živčnost, srčne učinke kot so tahikardija, aritmija, hipertenzija in zvišan utripni volumen, presnovne in prehranske motnje, kot je hiperglikemija.
Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure indicating little relevance to clinical use.
V predkliničnih študijah so zabeležili učinke le pri izpostavljenosti, ki naj bi znatno presegala maksimalno izpostavljenost pri človeku, kar kaže, da je to za klinično uporabo manj pomembno.
Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure, indicating little relevance to clinical use.
Učinke so v predkliničnih študijah opazili samo pri izpostavljenosti, ki je zadostno presegala največjo izpostavljenost pri človeku, kar kaže na majhen pomen za klinično uporabo.
Effects in nonclinical studies with respect to cardiovascular parameters (increased heart rates in dogs), reproductive toxicity (fetotoxic effects), and fertility (slight decreases in conception rate, number of corpora lutea, and pre- and post-implantation losses) were observed only at exposures considered sufficiently in excess of the maximum human exposure indication to be of little relevance to clinical use.
V predkliničnih študijah so učinke, povezane s kardiovaskularnimi parametri (pospešen srčni utrip pri psih), reprodukcijsko toksičnostjo (fetotoksični učinki) in plodnostjo (rahlo zmanjšanje v stopnji spočetij, število rumenih teles ter pred- in poimplantacijskih izgub), opazili samo pri izpostavljenostih, ki presegajo največjo indikacijo za izpostavljenost ljudi, kar je za klinično uporabo majhnega pomena.
Effects in repeated dose studies were observed only at exposures considered sufficiently in excess (>25-, >45-, and >35-fold for mice, rats, and dogs, respectively) of the maximum human exposure of ivacaftor when administered as Orkambi, indicating little relevance to clinical use.
Učinke v študijah ponavljajočih se odmerkov so ugotovili samo pri izpostavljenostih, za katere menimo, da dovolj presegajo (>25-, >45- in >35-krat za miši, podgane oziroma pse) največjo izpostavljenost ivakaftorju pri človeku, kadar ga uporabljamo v obliki zdravila Orkambi, kar kaže na majhen pomen za klinično uporabo.
Effects in the eye droopy eyelid (making the eye stay half closed).
Učinki na oko povešenost veke (oko ostane na pol zaprto)
Effects in the eye eye redness.
Učinki na oko rdečina očesa
Effects in the eye inflammation of the eye surface, inflammation of the eyelid, swollen conjunctiva, , increased growth of eyelashes, iris inflammation, eye inflammation, sensitivity to light, reduced vision, tired eyes, eye allergy, eye swelling, increased tear production, eyelid redness, eyelid colour change.
Učinki na oko vnetje površine očesa, vnetje očesne veke, otekla veznica, povečana rast trepalnic, vnetje šarenice, vnetje očesa, občutljivost na svetlobo, zmanjšan vid, utrujene oči, očesna alergija, otekanje oči, povečano nastajanje solz, rdečina vek, sprememba barve vek
Effects in the eye: allergic conjunctivitis (eye allergy), eye surface inflammation, eye pain, eye discomfort, blurred or abnormal vision, eye redness
Učinki na oko: alergijski konjunktivitis (očesna alergija), vnetje površine očesa, očesna bolečina, neprijeten občutek v očesu, zamegljen ali neobičajen vid, rdečina očesa
Effects in the eye: blurred vision, eye irritation, eye pain, eye discharge, itchy eye, dry eye, abnormal eye sensation, redness of the eye.
Učinki na oko: zamegljen vid, draženje očesa, očesna bolečina, izcedek iz očesa, srbeče oko, suho oko, nenavaden občutek v očesu, rdečina očesa
Effects in the eye: blurred vision, signs and symptoms of eye irritation (e.g burning, stinging, itching, tearing, redness), eye pain.
Učinki na oko: zamegljen vid, znaki in simptomi draženja očesa (npr. pekoč občutek, zbadanje, srbenje, solzenje, rdečina), očesna bolečina.
Effects in the eye: blurred, reduced, or abnormal vision, corneal disorder, eye surface inflammation with or without surface damage, inflammation or infection of the conjunctiva, eye discharge, sensitivity to light, increased tear production, itchy eye, redness of the eye, eyelid abnormality, itching, redness, swelling, or crusting of the eyelid.
Očesni učinki: zamegljen, oslabljen ali nenormalen vid, bolezni roženice, vnetje očesne površine z ali brez površinske poškodbe, vnetje ali okužba veznice, izcedek iz očesa, občutljivost za svetlobo, povečano solzenje, srbenje očesa, rdečina očesa, anomalije očesnih vek, srbenje, rdečina, otekanje ali kraste na veki.
Effects in the eye: corneal disorder, abnormal eye sensation, increased tear production, tired eyes, eye irritation, blurred vision, corneal staining, dry eye.
Učinki na oči: motnje roženice, nenormalen občutek v očesu, povečano nastajanje solz, utrujene oči, draženje očesa, zamegljen vid, obarvanje roženice, suho oko
Effects in the eye: corneal disorder, eye inflammation, iris inflammation, inflammation inside the eye, eye surface inflammation with/out surface damage, sensitivity to light, eye discharge, eyelid inflammation, eyelid redness, swelling around the eye, eyelid itching, reduced vision, blurred vision, increased tear production, infection or inflammation of the conjunctiva (conjunctivitis), abnormal turning outward of the lower eyelid, clouding of the eye, eyelid crusting, growth of eyelashes, discolouration of the eyelashes, tired eyes.
Učinki na oko: bolezen roženice, vnetje očesa, vnetje šarenice, vnetje v notranjosti očesa, vnetje očesne površine z ali brez poškodbe površine, občutljivost na svetlobo, izcedek iz očesa, vnetje veke, rdečina veke, otekanje okrog očesa, srbenje veke, zmanjšan vid, zamegljen vid, povečano nastajanje solz, okužba ali vnetje veznice (konjunktivitis), neobičajno navzven zavihana spodnja veka, motnost očesa, kraste na robovih vek, rast trepalnic, potemnitev trepalnic, utrujene oči
Effects in the eye: corneal disorder, eye inflammation, perception of flashing light, eye surface inflammation with/our surface damage, eyelid inflammation, eye swelling, inflammation or infection of the conjunctiva, halo vision, decrease eye sensation, pigmentation inside the eye, cataract, eyelid crusting, tired eyes, increase in pupil size, abnormal turning outward of the lower eyelid, loss of eyelashes, eye viral infection
Učinki na oko: bolezen roženice, očesno vnetje, zaznavanje svetlobnih bliskov, vnetje očesne površine z ali brez poškodbe površine, vnetje očesnih vek, otekanje očesa, vnetje ali okužba veznice, odsev v obliki kolobarjev, zmanjšan občutek očesa, pigmentacija znotraj očesa, katarakta, kraste na robovih vek, utrujene oči, razširjena zenica, nenavadno obračanje spodnje veke navzven, izguba trepalnic, virusna očesna okužba
Effects in the eye: corneal erosion (damage to the front layer of the eyeball), inflammation inside the eye, sensitivity to light, abnormal sensation in the eyes, eye discharge, dry eye, tired eyes, crusting of the eyelid.
Učinki na oko: erozija roženice (poškodba sprednjega sloja očesnega zrkla), vnetje v notranjosti očesa, občutljivost na svetlobo, nenormalen občutek v očesu, izcedek iz očesa, suho oko, utrujene oči, kraste na vekah.
Effects in the eye: corneal swelling, double or reduced vision, abnormal vision, decreased eye sensation, swelling around the eye, increased pressure in eye, damage to the optic nerve.
Učinki na oko: otekanje roženice, dvojni ali zmanjšan vid, nenormalen vid, zmanjšan občutek v očesu, otekanje okrog očesa, zvišan očesni tlak, poškodba vidnega živca
Effects in the eye: damage of the surface of the eye such as thinning or perforation, impaired healing of the eye, eye surface scar, clouding, reduced vision, eye swelling, blurred vision.
Učinki v očesu: poškodba očesne površine, kot je tanjšanje ali predrtje, slabše celjenje očesa, brazgotine na površini očesa, motnjava, poslabšanje vida, oteklost očesa, zamegljen vid
Effects in the eye: damage on the surface of the eye such as thinning or perforation, impaired healing of the eye, eye surface scar, clouding, reduced vision, eye swelling, blurred vision.
Učinki v očesu: poškodba očesne površine, kot je tanjšanje ali predrtje, slabše celjenje očesa, brazgotine na površini očesa, motnjava, poslabšanje vida, oteklost očesa, zamegljen vid
Effects in the eye: decreased growth of eyelashes
Učinki na oko: zmanjšana rast trepalnic.
Effects in the eye: decreased pupil size
Učinki na oko: zoženje zenice.
Effects in the eye: disturbance of vision, damage to the optic nerve, increased pressure in eye, deposits on the eye surface, corneal disorder, decreased eye sensation, inflammation or infection of the conjunctiva, abnormal, double or reduced vision, increased pigmentation of the eye, growth on surface of eye, increased tear production, eye swelling, sensitivity to light, decreased growth or number of eyelashes, drooping of the upper eyelids (making the eye stay half closed), inflammation of the eyelid and eye lid glands, inflammation in the cornea and detachment of the layer below the retina that contains blood vessels following filtration surgery which may cause visual disturbances, decreased corneal sensitivity.
Učinki na oko: motnje vida, okvara vidnega živca, zvišan očesni tlak, obloge na površini očesa, bolezen roženice, zmanjšana občutljivost očesa, vnetje ali okužba veznice, nenormalen, dvojni ali zmanjšan vid, povečana pigmentacija očesa, izrastek na površini očesa, povečano nastajanje solz, otekanje očesa, občutljivost na svetlobo, zmanjšana rast ali število trepalnic, povešenost zgornjih očesnih vek (oko ostane na pol zaprto), vnetje vek in žlez na očesnih vekah, vnetje v roženici in po filtracijskem posegu odstop plasti pod mrežnico, ki vsebuje krvne žile, kar lahko povzroči motnje vida, zmanšjano občutljivost roženice.
Effects in the eye: eye pain, eye irritation, dry eye, abnormal eye sensation, eye discomfort
Očesni učinki: očesna bolečina, draženje očesa, suho oko, nenormalen občutek v očesu, neprijeten občutek v očesu.
Effects in the eye: eye pain, itchy eye, eye redness
Učinki na oči: očesna bolečina, srbenje očesa, rdečina očesa
Effects in the eye: eye redness
Učinki na oko: rdečina očesa
Effects in the eye: eye surface damage with loss of cells, inflammation of the eyelid, deposits on the eye surface, sensitivity to light, swelling of the eye (affecting the cornea or eyelid), dry eye, eye discharge, watery eye, eyelid redness, abnormal or decreased sensation in eye, tired eye, reduced vision, double vision, product particles in eyes.
Učinki na oko: poškodba površine očesa z izgubo celic, vnetje očesne veke, oborine na površini očesa, občutljivost na svetlobo, otekanje očesa (roženice ali očesne veke), suho oko, izcedek iz očesa, zasolzeno oko, rdečina očesnih vek, neobičajen ali zmanjšan občutek v očesu, utrujene oči, slabši vid, dvojni vid, delci zdravila v očesu.
Effects in the eye: eye surface inflammation with or without loss or damage of cells, foreign body sensation in the eyes, eyelid crusting or drooping.
Učinki v očesu: vnetje površine očesa z ali brez izgube ali poškodbe celic, občutek tujka v očeh, kraste na robovih vek ali povešena veka
Effects in the eye: eyelid abnormality, visual disturbance, corneal disorder, eye allergy, decreased growth or number of eyelashes.
Učinki na oko: nepravilnosti vek, motnje vida, bolezen roženice, očesna alergija, zmanjšana rast ali število trepalnic
Effects in the eye: inflammation inside the eye, eye pain, eye surface inflammation with/out surface damage, eye discomfort, eye discharge, sensitivity to light, blurred or abnormal vision, dry eye, itchy eye, increased tear production, eyelid redness, swelling of the eyelid; discolouration of the eyelashes, growth of eyelashes, skin darkening or discolouration around the eye(s)
Učinki na oko: vnetje v notranjosti očesa, očesna bolečina, vnetje očesne površine z ali brez poškodbe površine, neprijeten občutek v očesu, izcedek iz očesa, občutljivost na svetlobo, zamegljen ali neobičajen vid, suho oko, srbeče oko, povečano nastajanje solz, rdečina očesnih vek, otekanje očesnih vek, sprememba barve trepalnic, rast trepalnic, potemnitev ali sprememba barve kože okrog očesa (oči)
Effects in the eye: inflammation inside the eye, eye surface inflammation with/out surface damage, inflammation of the eyelids, inflammation of the conjunctiva, eye pain, sensitivity to light, blurred or abnormal vision, swelling or crusting of eyelids, eye discharge, darkening of skin around the eye(s), growth and change in the texture of the eyelashes
Učinki na oko: vnetje v notranjosti očesa, vnetje očesne površine z ali brez poškodbe površine, vnetje očesnih vek, vnetje veznice, očesna bolečina, občutljivost na svetlobo, zamegljen ali neobičajen vid, otekanje ali kraste na robovih vek, izcedek iz očesa, potemnitev kože okrog očesa (oči), rast in sprememba teksture trepalnic
Effects in the eye: inflammation of the back of the eye, eyes appear more inset
Učinki na oko: vnetje zadnjega dela očesa, izgled udrtih oči
Effects in the eye: inflammation of the eyelid, inflammation in the cornea, detachment of the layer below the retina that contains blood vessels following filtration surgery which may cause visual disturbances, decreased corneal sensitivity, corneal erosion (damage to the front layer of the eyeball), double vision, changes in the colour of the iris.
Učinki na oko: vnetje očesnih vek, vnetje v roženici, po filtracijskem posegu odstop plasti pod mrežnico, ki vsebuje krvne žile, kar lahko povzroči motnje vida, zmanšjano občutljivost roženice, erozijo roženice (poškodbo sprednjega sloja očesnega zrkla), dvojni vid, spremembe barve šarenice
Effects in the eye: iris inflammation, eye pain, eye discomfort, dry eye, eyelid swelling, eye irritation, itchy eye, eye discharge, allergic conjunctivitis (eye allergy), increased tear production, deposits on the eye surface, fluid or swelling at the back of the eye, eye redness.
Učinki v očesu: vnetje šarenice, očesna bolečina, neprijeten občutek v očesu, suho oko, oteklost veke, draženje očesa, srbeče oko, izcedek iz očesa, alergijski konjunktivitis (očesna alergija), povečano nastajanje solz, depoziti na površini očesa, tekočina ali oteklost v ozadju očesa, rdečina očesa
Effects in the eye: perception of flashing lights, eczema of the eyelids, eye swelling, halo vision, decreased eye sensation, inflammation of the glands of the eyelids, pigmentation inside the eye, increase in pupil size, change in the texture of the eyelashes.
Učinki na oko: zaznavanje svetlobnih bliskov, ekcem vek, otekanje očesa, odsev v obliki kolobarjev, zmanjšan občutek očesa, vnetje žlez na vekah, pigmentacija znotraj očesa, razširjena zenica, sprememba teksture trepalnic
Effects in the eye: sensitivity to light, inflammation or infection of the conjunctiva, eye swelling, eyelid itching, redness or swelling, growth on surface of eye, increased pigmentation of the eye, tired eyes, eyelid crusting, or increased tear production.
Učinki na oko: občutljivost za svetlobo, vnetje ali okužba veznice, otekanje očesa, srbenje, rdečina ali otekanje vek, izrastek na površini očesa, povečana pigmentiranost očesa, utrujene oči, kraste na vekah ali povečano nastajanje solz
effects including
učinki, vključno
effects listed above)
o navedeni zgoraj)
Effects observed in repeat-dose toxicity studies were mainly due to the exaggerated pharmacodynamic activity of rivaroxaban.
Učinki, ki so jih opazili v študijah toksičnosti ponavljajočih odmerkov, so se pojavili večinoma zaradi povečanega farmakodinamičnega delovanja rivaroksabana.
Effects observed in the repeat-dose toxicity studies were due to the exaggerated pharmacodynamic effect of dabigatran.
Učinki, ki so jih zasledili v študijah toksičnosti ponavljajočih odmerkov, so bili posledica prekomernega farmakodinamičnega učinka dabigatrana.
Effects of aclidinium in nonclinical studies with respect to reproductive toxicity (fetotoxic effects) and fertility (slight decreases in conception rate, number of corpora lutea, and pre- and post-implantation losses) were observed only at exposures considered sufficiently in excess of the maximum human exposure indication to be of little relevance to clinical use.
V nekliničnih študijah so učinke aklidinija, povezane z reprodukcijsko toksičnostjo (fetotoksični učinki) in plodnostjo (rahlo zmanjšanje v stopnji spočetij, številu rumenih teles ter pred- in poimplantacijskih izgub), opazili samo pri izpostavljenostih, ki bistveno presegajo največjo indikacijo za izpostavljenost ljudi, kar je za klinično uporabo majhnega pomena.
Effects of alirocumab on other medicinal products
Vpliv alirokumaba na druga zdravila
Effects of amlodipine on other medicinal products
Vpliv amlodipina na druga zdravila
Effects of anagrelide on other active substances
Učinki anagrelida na druge zdravilne učinkovine
Effects of apremilast on pregnancy included embryofetal loss in mice and monkeys, and reduced fetal weights and delayed ossification in mice at doses higher than the currently recommended highest human dose.
Učinki apremilasta na nosečnost so vključevali izgubo zarodka in ploda pri miših in opicah in zmanjšano telesno maso ploda ter zapoznelo osifikacijo pri miših pri odmerkih, ki so bili večji od trenutno priporočenega največjega odmerka za človeka.
Effects of bexarotene on other substances: there are indications that bexarotene may induce CYP3A4.
Učinki beksarotena na druge snovi: Obstajajo znaki, da beksaroten lahko povzroči indukcijo CYP3A4.
Effects of brivaracetam on other medicinal products
Učinki brivaracetama na druga zdravila
Effects of canagliflozin on other medicinal products Digoxin
Vpliv kanagliflozina na druge učinkovine Digoksin
Effects of concomitant medicines on vemurafenib
Vplivi sočasno uporabljenih zdravil na vemurafenib
Effects of dabrafenib on other substances
Vplivi dabrafeniba na druge snovi
Effects of darifenacin on other medicinal products
Vpliv darifenacina na druga zdravila
Effects of dexamethasone on other medicinal products
Vpliv deksametazona na druga zdravila
Effects of Efient on other medicinal products
Učinki zdravila Efient na druga zdravila
Effects of esomeprazole on the pharmacokinetics of other medicinal products
Učinki esomeprazola na farmakokinetiko drugih zdravil
Effects of Fexeric on other medicinal products
Učinki zdravila Fexeric na druga zdravila
Effects of gender
Vpliv spola
Effects of insulin glargine (once daily) on diabetic retinopathy were evaluated in an open-label 5 year NPH-controlled study (NPH given bid) in 1024 type 2 diabetic patients in which progression of retinopathy by 3 or more steps on the Early Treatment Diabetic Retinopathy Study (ETDRS) scale was investigated by fundus photography.
Učinke insulina glargin (enkrat na dan) na diabetično retinopatijo so raziskali v odprti, petletni, z NPH kontrolirani študiji (NPH apliciran dvakrat na dan) pri 1.024 bolnikih z diabetesom tipa 2, pri katerih so napredek retinopatije za tri ali več stopenj po lestvici ETDRS (Early Treatment Diabetic Retinopathy Study) preiskovali s slikanjem očesnega ozadja.
Effects of Ketoconazole HRA on the metabolism of the other medicinal products
Učinki zdravila Ketokonazol HRA na presnovo drugih zdravil
Effects of mercaptopurine on other medicinal products
Učinki merkaptopurina na druga zdravila